IL6 and neoplasm: GP130 is emerging as attractive and promising therapeutic target for cancer therapy, because accumulating data demonstrated IL-6/GP130 signaling plays critical role in tumorigenesis, tumor proliferation, metastasis, and chemoresistance in multiple types of tumors.